{"transactions":[{"id":1327436,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-12-18T21:02:59.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":304,"price":730.81,"value":222166.24,"ownership":{"direct":true},"balance_after":48829,"source":{"system":"sec-edgar","filing":"0001968202-24-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000141/edgardoc.xml","form_type":"4"}},{"id":1338115,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:24.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":466,"price":787,"value":366742.0,"ownership":{"direct":true},"balance_after":49133,"source":{"system":"sec-edgar","filing":"0001968202-24-000138","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000138/edgardoc.xml","form_type":"4"}},{"id":1434180,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-14T20:01:19.000Z","date":"2024-08-13","kind":"gift","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49599,"source":{"system":"sec-edgar","filing":"0001968202-24-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000117/edgardoc.xml","form_type":"4"}},{"id":1436376,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-12","kind":"gift","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50099,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436375,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":300,"price":1086.15,"value":325845.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":50999,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436374,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":1708,"price":1085.01,"value":1853197.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":51299,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436373,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":1883,"price":1084.61,"value":2042320.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":53007,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436372,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":1006,"price":1083.76,"value":1090262.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":54890,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436371,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":200,"price":1082.69,"value":216538.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":55896,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1436370,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-12T20:05:11.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":100,"price":1081.83,"value":108183.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price."}],"balance_after":56096,"source":{"system":"sec-edgar","filing":"0001968202-24-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000115/edgardoc.xml","form_type":"4"}},{"id":1439946,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-08-06T20:03:46.000Z","date":"2024-08-02","kind":"exercise","planned":false,"acquired":false,"shares":23638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":23638},"source":{"system":"sec-edgar","filing":"0001968202-24-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000113/edgardoc.xml","form_type":"4"}},{"id":1439945,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-06T20:03:46.000Z","date":"2024-08-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":18441,"price":1093.49,"value":20165049.09,"ownership":{"direct":true},"balance_after":56196,"source":{"system":"sec-edgar","filing":"0001968202-24-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000113/edgardoc.xml","form_type":"4"}},{"id":1439944,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-08-06T20:03:46.000Z","date":"2024-08-02","kind":"exercise","planned":false,"acquired":true,"shares":23638,"price":555.67,"value":13134927.46,"ownership":{"direct":true},"balance_after":74637,"source":{"system":"sec-edgar","filing":"0001968202-24-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000113/edgardoc.xml","form_type":"4"}},{"id":1613531,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:05.000Z","date":"2024-02-26","kind":"gift","planned":false,"acquired":false,"shares":1020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50999,"source":{"system":"sec-edgar","filing":"0001968202-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000078/edgardoc.xml","form_type":"4"}},{"id":1654332,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":19,"price":953,"value":18107.0,"ownership":{"direct":true},"balance_after":52019,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654331,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":1059,"price":952.49,"value":1008686.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price."}],"balance_after":52038,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654330,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":1237,"price":951.49,"value":1176993.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price."}],"balance_after":53097,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654329,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":3127,"price":950.43,"value":2971994.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price."}],"balance_after":54334,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654328,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":601,"price":949.45,"value":570619.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price."}],"balance_after":57461,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654327,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":1894,"price":948.69,"value":1796818.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price."}],"balance_after":58062,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1654326,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-08T21:02:33.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":100,"price":947.34,"value":94734.0,"ownership":{"direct":true},"balance_after":59956,"source":{"system":"sec-edgar","filing":"0001968202-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000056/edgardoc.xml","form_type":"4"}},{"id":1657477,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-06T21:08:32.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":false,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":30750},"source":{"system":"sec-edgar","filing":"0001968202-24-000054","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000054/edgardoc.xml","form_type":"4"}},{"id":1657476,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-06T21:08:32.000Z","date":"2024-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":22713,"price":956.65,"value":21728391.45,"ownership":{"direct":true},"balance_after":60056,"source":{"system":"sec-edgar","filing":"0001968202-24-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000054/edgardoc.xml","form_type":"4"}},{"id":1657475,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2024-02-06T21:08:32.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":true,"shares":30750,"price":399.66,"value":12289545.0,"ownership":{"direct":true},"balance_after":82769,"source":{"system":"sec-edgar","filing":"0001968202-24-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000054/edgardoc.xml","form_type":"4"}},{"id":1715290,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-12T21:05:27.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":3059,"derivative":{"exercise_price":843.79,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001883850-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000090/edgardoc.xml","form_type":"4"}},{"id":1715289,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:27.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":725,"price":844.09,"value":611965.25,"ownership":{"direct":true},"balance_after":52019,"source":{"system":"sec-edgar","filing":"0001883850-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000090/edgardoc.xml","form_type":"4"}},{"id":1715288,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:27.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2025 and 50% on December 8, 2027."}],"balance_after":52744,"source":{"system":"sec-edgar","filing":"0001883850-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000090/edgardoc.xml","form_type":"4"}},{"id":1715287,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:27.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":809,"price":843.79,"value":682626.11,"ownership":{"direct":true},"balance_after":51891,"source":{"system":"sec-edgar","filing":"0001883850-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000090/edgardoc.xml","form_type":"4"}},{"id":1742954,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-11-14T21:03:30.000Z","date":"2023-11-10","kind":"gift","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52700,"source":{"system":"sec-edgar","filing":"0001968202-23-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000040/edgardoc.xml","form_type":"4"}},{"id":1799053,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-21","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":30750,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":1799052,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":782,"price":842.16,"value":658569.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 782 shares of Company stock on August 22, 2023 at prices ranging from $842.01 to $842.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price."}],"balance_after":53100,"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":1799051,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":4574,"price":841.41,"value":3848609.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 4,574 shares of Company stock on August 22, 2023 at prices ranging from $841.01 to $841.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price."}],"balance_after":53882,"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":1799050,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":6309,"price":840.53,"value":5302903.77,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 6,309 shares of Company stock on August 22, 2023 at prices ranging from $840.00 to $840.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price."}],"balance_after":58456,"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":1799049,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":38335,"price":833.39,"value":31948005.65,"ownership":{"direct":true},"balance_after":64765,"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":1799048,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2023-08-23T20:03:35.000Z","date":"2023-08-21","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":399.66,"value":19983000.0,"ownership":{"direct":true},"balance_after":103100,"source":{"system":"sec-edgar","filing":"0001968202-23-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000023/edgardoc.xml","form_type":"4"}},{"id":2080318,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T21:08:43.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":4063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":4063,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":4063},"source":{"system":"sec-edgar","filing":"0001883850-22-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000136/edgardoc.xml","form_type":"4"}},{"id":2080317,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-12-20T21:08:43.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":1101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026."}],"balance_after":53100,"source":{"system":"sec-edgar","filing":"0001883850-22-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000136/edgardoc.xml","form_type":"4"}},{"id":2088764,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-12-13T21:11:18.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":466,"price":753.28,"value":351028.48,"ownership":{"direct":true},"balance_after":51999,"source":{"system":"sec-edgar","filing":"0001883850-22-000119","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000119/edgardoc.xml","form_type":"4"}},{"id":2088763,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-12-13T21:11:18.000Z","date":"2022-11-08","kind":"gift","acquired":false,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52465,"source":{"system":"sec-edgar","filing":"0001883850-22-000119","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000119/edgardoc.xml","form_type":"4"}},{"id":2192353,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-04","kind":"exercise","acquired":false,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192352,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":100,"price":621.11,"value":62111.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents volume-weighted average price of sales of 100 shares of Company stock on August 5, 2022 at prices ranging from $621.09 to $621.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":52795,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192351,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":177,"price":620.11,"value":109759.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents volume-weighted average price of sales of 177 shares of Company stock on August 5, 2022 at prices ranging from $620.11 to $620.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":52895,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192350,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":502,"price":619.64,"value":311059.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents volume-weighted average price of sales of 502 shares of Company stock on August 5, 2022 at prices ranging from $619.00 to $619.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":53072,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192349,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":521,"price":618.27,"value":322118.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 521 shares of Company stock on August 5, 2022 at prices ranging from $618.06 to $618.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":53574,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192348,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":424,"price":617.43,"value":261790.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 424 shares of Company stock on August 5, 2022 at prices ranging from $617.04 to $617.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":54095,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192347,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":535,"price":616.4,"value":329774.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 535 shares of Company stock on August 5, 2022 at prices ranging from $616.08 to $616.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":54519,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":1610,"price":615.49,"value":990938.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 1,610 shares of Company stock on August 5, 2022 at prices ranging from $615.00 to $615.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":55054,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192345,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":4112,"price":614.35,"value":2526207.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 4,112 shares of Company stock on August 5, 2022 at prices ranging from $614.00 to $614.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":56664,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192344,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":3218,"price":613.49,"value":1974210.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 3,218 shares of Company stock on August 5, 2022 at prices ranging from $613.00 to $613.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":60776,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192343,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":2076,"price":612.43,"value":1271404.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 2,076 shares of Company stock on August 5, 2022 at prices ranging from $612.00 to $612.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":63994,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192342,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":2022,"price":611.44,"value":1236331.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 2,022 shares of Company stock on August 5, 2022 at prices ranging from $611.00 to $611.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":66070,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192341,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":3931,"price":610.49,"value":2399836.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 3,931 shares of Company stock on August 5, 2022 at prices ranging from $610.00 to $610.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":68092,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192340,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":3044,"price":609.62,"value":1855683.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 3,044 shares of Company stock on August 5, 2022 at prices ranging from $609.00 to $609.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":72023,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192339,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":610,"price":608.7,"value":371307.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 610 shares of Company stock on August 5, 2022 at prices ranging from $608.03 to $608.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":75067,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192338,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":724,"price":607.47,"value":439808.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 724 shares of Company stock on August 5, 2022 at prices ranging from $607.00 to $607.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":75677,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192337,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":176,"price":606.78,"value":106793.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 176 shares of Company stock on August 5, 2022 at prices ranging from $606.60 to $606.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2022 at each separate price."}],"balance_after":76401,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192336,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-04","kind":"tax_withholding","acquired":false,"shares":71218,"price":613,"value":43656634.0,"ownership":{"direct":true},"balance_after":76577,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192335,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-08-04","kind":"exercise","acquired":true,"shares":95000,"price":270.43,"value":25690850.0,"ownership":{"direct":true},"balance_after":147795,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2192334,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2022-08-08T20:11:50.000Z","date":"2022-02-18","kind":"gift","acquired":false,"shares":335,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52795,"source":{"system":"sec-edgar","filing":"0001883850-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000053/edgardoc.xml","form_type":"4"}},{"id":2474344,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-14T21:08:00.000Z","date":"2021-12-11","kind":"tax_withholding","acquired":false,"shares":753,"price":664.34,"value":500248.02,"ownership":{"direct":true},"balance_after":53130,"source":{"system":"sec-edgar","filing":"0001708138-21-000104","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000104/edgardoc.xml","form_type":"4"}},{"id":2477918,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-10T22:35:01.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":12494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12494,"derivative":{"exercise_price":644.54,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":12494},"source":{"system":"sec-edgar","filing":"0001708138-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000093/edgardoc.xml","form_type":"4"}},{"id":2477917,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-10T22:35:01.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":2926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025."}],"balance_after":53883,"source":{"system":"sec-edgar","filing":"0001708138-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000093/edgardoc.xml","form_type":"4"}},{"id":2484369,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-06T21:10:07.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":72500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":72500},"source":{"system":"sec-edgar","filing":"0001883850-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000018/edgardoc.xml","form_type":"4"}},{"id":2484368,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-06T21:10:07.000Z","date":"2021-11-29","kind":"gift","acquired":true,"shares":4605,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"balance_after":4605,"source":{"system":"sec-edgar","filing":"0001883850-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000018/edgardoc.xml","form_type":"4"}},{"id":2484367,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-06T21:10:07.000Z","date":"2021-12-03","kind":"tax_withholding","acquired":false,"shares":50352,"price":632.45,"value":31845122.4,"ownership":{"direct":true},"balance_after":50957,"source":{"system":"sec-edgar","filing":"0001883850-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000018/edgardoc.xml","form_type":"4"}},{"id":2484366,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-06T21:10:07.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":72500,"price":179.13,"value":12986925.0,"ownership":{"direct":true},"balance_after":101309,"source":{"system":"sec-edgar","filing":"0001883850-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000018/edgardoc.xml","form_type":"4"}},{"id":2484365,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-12-06T21:10:07.000Z","date":"2021-11-29","kind":"gift","acquired":false,"shares":4605,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28809,"source":{"system":"sec-edgar","filing":"0001883850-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000018/edgardoc.xml","form_type":"4"}},{"id":2709110,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":72500,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709109,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable on December 31, 2014, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2014."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":3806,"price":520.17,"value":1979767.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 3,806 shares of Company stock on May 17, 2021 at prices ranging from $520.02 to $520.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price."}],"balance_after":24280,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709107,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":10336,"price":519.47,"value":5369241.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 10,336 shares of Company stock on May 17, 2021 at prices ranging from $519.00 to $519.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price."}],"balance_after":28086,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709106,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":3379,"price":518.63,"value":1752450.77,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 3,379 shares of Company stock on May 17, 2021 at prices ranging from $518.02 to $518.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price."}],"balance_after":38422,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709105,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"tax_withholding","acquired":false,"shares":7204,"price":516.69,"value":3722234.76,"ownership":{"direct":true},"balance_after":41801,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709104,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"exercise","acquired":true,"shares":12500,"price":52.03,"value":650375.0,"ownership":{"direct":true},"balance_after":49005,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709103,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"tax_withholding","acquired":false,"shares":27775,"price":516.69,"value":14351064.75,"ownership":{"direct":true},"balance_after":36505,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709102,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-05-14","kind":"exercise","acquired":true,"shares":40000,"price":179.13,"value":7165200.0,"ownership":{"direct":true},"balance_after":64280,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2709101,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2021-05-18T20:04:14.000Z","date":"2021-02-25","kind":"gift","acquired":false,"shares":435,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24280,"source":{"system":"sec-edgar","filing":"0001708138-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000020/edgardoc.xml","form_type":"4"}},{"id":2949276,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-11T21:05:33.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":17500,"derivative":{"exercise_price":492,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001237899-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000052/edgardoc.xml","form_type":"4"}},{"id":2949275,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:33.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":1688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024."}],"balance_after":24715,"source":{"system":"sec-edgar","filing":"0001237899-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000052/edgardoc.xml","form_type":"4"}},{"id":2949274,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:33.000Z","date":"2020-02-26","kind":"gift","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20979,"source":{"system":"sec-edgar","filing":"0001237899-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000052/edgardoc.xml","form_type":"4"}},{"id":3155249,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"With respect to 75,000 underlying shares (of which 12,500 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by the\ncompany of certain performance criteria during the period ended December 31, 2014."}],"balance_after":12500,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155248,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":2026,"price":570.28,"value":1155387.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 2,026 shares of Company stock on May 11, 2020 at prices ranging from $570.00 to $570.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price."}],"balance_after":11380,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155247,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":2175,"price":569.39,"value":1238423.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 2,175 shares of Company stock on May 11, 2020 at prices ranging from $569.00 to $569.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price."}],"balance_after":13406,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155246,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":792,"price":568.71,"value":450418.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 792 shares of Company stock on May 11, 2020 at prices ranging from $568.00 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price."}],"balance_after":15581,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155245,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":312,"price":567.5,"value":177060.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 312 shares of Company stock on May 11, 2020 at prices ranging from $567.11 to $567.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price."}],"balance_after":16373,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155244,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-08","kind":"tax_withholding","acquired":false,"shares":7195,"price":560.67,"value":4034020.65,"ownership":{"direct":true},"balance_after":16685,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3155243,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-05-11T20:39:21.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":12500,"price":52.03,"value":650375.0,"ownership":{"direct":true},"balance_after":23880,"source":{"system":"sec-edgar","filing":"0001708138-20-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000054/edgardoc.xml","form_type":"4"}},{"id":3176855,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":13079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"With respect to 75,000 underlying shares (of which 25,000 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":13079},"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176854,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":357,"price":524.26,"value":187160.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 357 shares of Company stock on April 14, 2020 at prices ranging from $524.00 to $524.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":11380,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176853,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":758,"price":522.37,"value":395956.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 758 shares of Company stock on April 14, 2020 at prices ranging from $522.00 to $522.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":11737,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176852,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":1595,"price":521.32,"value":831505.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,595 shares of Company stock on April 14, 2020 at prices ranging from $521.01 to $521.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":12495,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176851,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":2096,"price":520.43,"value":1090821.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 2,096 shares of Company stock on April 14, 2020 at prices ranging from $520.01 to $520.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":14090,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176850,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":422,"price":519.85,"value":219376.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 422 shares of Company stock on April 14, 2020 at prices ranging from $519.27 to $519.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":16186,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176849,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":267,"price":518.54,"value":138450.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 267 shares of Company stock on April 14, 2020 at prices ranging from $518.14 to $518.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price."}],"balance_after":16608,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176848,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":2,"price":517.99,"value":1035.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":16875,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176847,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-13","kind":"tax_withholding","acquired":false,"shares":7582,"price":511.56,"value":3878647.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":16877,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3176846,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-04-15T20:17:00.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":13079,"price":52.03,"value":680500.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":24459,"source":{"system":"sec-edgar","filing":"0001708138-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000034/edgardoc.xml","form_type":"4"}},{"id":3242279,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-02-28T21:40:39.000Z","date":"2020-02-26","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"With respect to 75,000 underlying shares (of which 25,000 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 13,079 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Form two of two"}],"balance_after":38079,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001708138-20-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000018/edgardoc.xml","form_type":"4"}},{"id":3242278,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-02-28T21:40:11.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":31,"price":468.56,"value":14525.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F24","text":"Form one of two"}],"balance_after":11380,"source":{"system":"sec-edgar","filing":"0001708138-20-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000017/edgardoc.xml","form_type":"4"}},{"id":3242277,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":84954,"kind":"person","name":"STAHL NEIL","position":1,"cik":"0001226689","reported_name":"STAHL NEIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research and Development"}}],"security":"Common Stock","published_at":"2020-02-28T21:40:11.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":227,"price":465.42,"value":105650.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F23","text":"Represents volume-weighted average price of sales of 227 shares of Company stock on February 27, 2020 at prices ranging from $465.04 to $465.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price."}],"balance_after":11411,"source":{"system":"sec-edgar","filing":"0001708138-20-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000017/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-02-28T21:40:11.000000Z,3242277"}